
@ShahidNShah
The next wave of coronavirus testing involves serology tests to identify antibodies that help fight off the infection.
Typically, the presence of the antibodies indicates that someone has been exposed to the virus and developed some level of immune response.
Roche’s Elecsys Anti-SARS-CoV-2 antibody test, which was approved under the Food and Drug Administration’s (FDA’s) emergency use authorization, is live at more than 20 hospital and commercial lab sites throughout the U.S.
In the coming weeks, that’s expected to increase to more than 200 sites that would be capable of performing millions of tests per week.
A full list of tests authorized by the FDA can be found here.
Continue reading at healthcarebusinesstech.com
A 15-year-old identity framework originally designed for narrow use by pharmaceutical companies is being revamped and updated for broader use in healthcare, says Kyle Neuman, managing director of SAFE …
Posted Jun 1, 2020cybersecurityhealthcare
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 24, 2025 at 4:44am